1. Home
  2. AVDL vs UAA Comparison

AVDL vs UAA Comparison

Compare AVDL & UAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.63

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Under Armour Inc.

UAA

Under Armour Inc.

HOLD

Current Price

$4.65

Market Cap

2.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVDL
UAA
Founded
2015
1996
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.2B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
AVDL
UAA
Price
$21.63
$4.65
Analyst Decision
Buy
Hold
Analyst Count
9
19
Target Price
$18.38
$6.34
AVG Volume (30 Days)
2.1M
9.4M
Earning Date
11-04-2025
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$248,517,000.00
$5,049,070,000.00
Revenue This Year
$65.47
N/A
Revenue Next Year
$30.88
$1.54
P/E Ratio
N/A
N/A
Revenue Growth
79.88
N/A
52 Week Low
$6.38
$4.13
52 Week High
$23.57
$8.72

Technical Indicators

Market Signals
Indicator
AVDL
UAA
Relative Strength Index (RSI) 61.54 56.97
Support Level $21.36 $4.26
Resistance Level $21.68 $4.64
Average True Range (ATR) 0.12 0.14
MACD -0.12 0.03
Stochastic Oscillator 74.68 90.00

Price Performance

Historical Comparison
AVDL
UAA

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About UAA Under Armour Inc.

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.

Share on Social Networks: